These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9000544)

  • 1. Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines.
    Garwicz D; Lindmark A; Hellmark T; Gladh M; Jögi J; Gullberg U
    J Leukoc Biol; 1997 Jan; 61(1):113-23. PubMed ID: 9000544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cathepsin G lacking functional glycosylation site is proteolytically processed and targeted for storage in granules after transfection to the rat basophilic/mast cell line RBL or the murine myeloid cell line 32D.
    Garwicz D; Lindmark A; Gullberg U
    J Biol Chem; 1995 Nov; 270(47):28413-8. PubMed ID: 7499346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processing of human cathepsin G after transfection to the rat basophilic/mast cell tumor line RBL.
    Gullberg U; Lindmark A; Nilsson E; Persson AM; Olsson I
    J Biol Chem; 1994 Oct; 269(40):25219-25. PubMed ID: 7929211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis-induced proteinase 3 membrane expression is independent from degranulation.
    Durant S; Pederzoli M; Lepelletier Y; Canteloup S; Nusbaum P; Lesavre P; Witko-Sarsat V
    J Leukoc Biol; 2004 Jan; 75(1):87-98. PubMed ID: 14525959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells.
    Van der Geld YM; Smook ML; Huitema MG; Harmsen MC; Limburg PC; Kallenberg CG
    J Immunol Methods; 2002 Jun; 264(1-2):195-205. PubMed ID: 12191522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a recombinant proteinase 3, the autoantigen in Wegener's granulomatosis and its reactivity with anti-neutrophil cytoplasmic autoantibodies.
    Witko-Sarsat V; Halbwachs-Mecarelli L; Almeida RP; Nusbaum P; Melchior M; Jamaleddine G; Lesavre P; Descamps-Latscha B; Gabay JE
    FEBS Lett; 1996 Mar; 382(1-2):130-6. PubMed ID: 8612734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human proteinase 3, the Wegener's autoantigen, expressed in HMC-1 cells is enzymatically active and recognized by c-ANCA.
    Specks U; Fass DN; Fautsch MP; Hummel AM; Viss MA
    FEBS Lett; 1996 Jul; 390(3):265-70. PubMed ID: 8706874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the biosynthesis, processing, and sorting of human HBP/CAP37/azurocidin.
    Lindmark A; Garwicz D; Rasmussen PB; Flodgaard H; Gullberg U
    J Leukoc Biol; 1999 Oct; 66(4):634-43. PubMed ID: 10534120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What you should know about PR3-ANCA. Conformational requirements of proteinase 3 (PR3) for enzymatic activity and recognition by PR3-ANCA.
    Specks U
    Arthritis Res; 2000; 2(4):263-7. PubMed ID: 11094439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and functional expression of the murine homologue of proteinase 3: implications for the design of murine models of vasculitis.
    Jenne DE; Fröhlich L; Hummel AM; Specks U
    FEBS Lett; 1997 May; 408(2):187-90. PubMed ID: 9187364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epitope mapping of anti-PR3 antibodies using chimeric human/mouse PR3 recombinant proteins.
    Selga D; Segelmark M; Wieslander J; Gunnarsson L; Hellmark T
    Clin Exp Immunol; 2004 Jan; 135(1):164-72. PubMed ID: 14678279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).
    Selak S; Woodman RC; Fritzler MJ
    Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.
    Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG
    Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
    Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
    Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane proteinase 3 and Wegener's granulomatosis.
    von Vietinghoff S; Schreiber A; Otto B; Choi M; Göbel U; Kettritz R
    Clin Nephrol; 2005 Dec; 64(6):453-9. PubMed ID: 16370159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.
    Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG
    Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.
    van de Wiel BA; Dolman KM; van der Meer-Gerritsen CH; Hack CE; von dem Borne AE; Goldschmeding R
    Clin Exp Immunol; 1992 Dec; 90(3):409-14. PubMed ID: 1458677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proportion of proteinase 3 (PR3)-specific anti-neutrophil cytoplasmic antibodies (ANCA) only react with PR3 after cleavage of its N-terminal activation dipeptide.
    Sun J; Fass DN; Viss MA; Hummel AM; Tang H; Homburger HA; Specks U
    Clin Exp Immunol; 1998 Nov; 114(2):320-6. PubMed ID: 9822293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis.
    van der Geld YM; Tool AT; Videler J; de Haas M; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG; Roos D
    Clin Exp Immunol; 2002 Sep; 129(3):562-70. PubMed ID: 12197900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA.
    Capizzi SA; Viss MA; Hummel AM; Fass DN; Specks U
    Kidney Int; 2003 Feb; 63(2):756-60. PubMed ID: 12631144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.